Background
Method
Study design
Study data
Case dataset
Control dataset
Annotation data
Statistical analyses
-
Identification of variants in known breast cancer-predisposing genes
-
Identification of variants in CPGs with no known association with breast cancer
-
Identification of somatically mutated germline variants. A germline variant able to favor carcinogenesis may have a higher chance of being also somatically mutated in cancer genomes [5]. We called these variants (“somatically mutated germline variants”, SMGVs). To identify SMGVs, we composed a large set of somatic variants from WGS and WES studies, combining the COSMIC and cBioPortal databases, and checked for possible matches between germline variants and somatic mutations (see Additional file 1: Annotation data).
Results
Hypothesis-driven analysis of rare variants in target cancer genes
Variants in known breast cancer-predisposing genes
Gene | Somatic driver gene | Total number of variants | Number of pathogenic variants | Number of truncating variants | Number of highly damaging mutations |
---|---|---|---|---|---|
ATM
| X | 21 | 5 | ||
BRCA1
| X | 18 | 2 | 3 | |
BRCA2
| X | 21 | 5 | 2 | |
BRIP1
| 5 | 1 | |||
CDH1
| X | 3 | 1 | ||
CHEK2
| X | 6 | 2 | 1 | |
MRE11A
| 4 | 1 | |||
NBN
| 5 | 1 | 2 | ||
PALB2
| 1 | ||||
PRKAR1A
| |||||
PTEN
| X | ||||
RAD50
| 5 | ||||
RAD51C
| 3 | 1 | |||
STK11
| X | 3 | |||
TP53
| X | 4 | 1 |
Variants in CPGs with no known association with breast cancer
Gene – variant | Control MAF | Case MAF | log2 MAF ratio | Summary of ClinVar and Humsavar annotations |
---|---|---|---|---|
COL7A1 - R1538C - (3,48619779,G,A)
| 0.002% | 0.07% | 5.35 | Malignant melanoma |
AKT1 - E17K - (14,105246551,C,T)
| Novel | 0.08% | 4.47 | Colon, ovary and breast cancer |
FANCC - R185* - (9,97912338,G,A)
| 0.006% | 0.07% | 3.76 | Fanconi anemia |
MSH6 - T955fs - (2,48030639,-,C)
| 0.213% | 2.61% | 3.62 | Lynch syndrome |
ELAC2 - R741H - (17,12896274,C,T)
| 0.072% | 0.23% | 1.66 | Prostate cancer |
RET - Y791F - (10,43613908,A,T)
| 0.244% | 0.69% | 1.50 | MEN2A syndrome/thyroid carcinoma |
FLCN - R239C - (17,17125879,G,A)
| 0.033% | 0.08% | 1.20 | Renal cell carcinoma |
PKHD1 - T36M - (6,51947999,G,A)
| 0.075% | 0.15% | 0.98 | Renal cancer |
GALNT12 - D303N - (9,101594229,G,A)
| 0.185% | 0.30% | 0.72 | Colorectal cancer |
PRF1 - N252S - (10,72358722,T,C)
| 0.501% | 0.82% | 0.72 | Non-Hodgkin lymphoma |
SDHD - G12S - (11,111957665,G,A)
| 0.992% | 1.04% | 0.07 | Cowden disease 3 |
Co-occurrence of known cancer-predisposing variants
Somatically mutated germline variants
Tumor suppressor-like analysis
Age-dependent polygenic model
Variant | Approved name | Control MAF | Case MAF | Protein change | Mean beta elastic net | Negative beta percentage |
---|---|---|---|---|---|---|
MRPL24 - 1,156708335,C,T
| Mitochondrial ribosomal protein L24 | Novel | 0.074% | W54*
| −2.78 | 1.00 |
CST4 - 20,23667825,-,C
| Cystatin S | 0.0129% | 0.300% | V81fs | −5.09 | 1.00 |
PARD6A - 16,67696278,C,T
| Par-6 family cell polarity regulator alpha | 0.0018% | 0.078% | R256* | −1.86 | 1.00 |
TRIOBP - 22,38121788,-,C
| TRIO and F-actin binding protein | 0.0059% | 0.471% | S1075fs | −3.64 | 1.00 |
ZNF85 - 19,21132125,C,T
| Zinc finger protein 85 | Novel | 0.085% | R205* | −4.36 | 1.00 |
FOXP4 - 6,41553185,A,G
| Forkhead box P4 | 0.0018% | 0.091% | K147R | −8.04 | 1.00 |
PKHD1 - 6,51890490,A,C
| Polycystic kidney and hepatic disease 1 (autosomal recessive) | Novel | 0.075% | M1373R | −5.33 | 1.00 |
SURF1 - 9,136218808,A,T
| Surfeit 1 | Novel | 0.081% | L179Q | −6.49 | 1.00 |
HIST2H2AB - 1,149859084,TT…GT,-
| Histone cluster 2, H2ab | Novel | 0.074% | T121fs | −3.59 | 0.97 |
STIM2 - 4,27004586,G,A
| Stromal interaction molecule 2 | Novel | 0.081% | V281I | −1.65 | 0.97 |
CPA3 - 3,148597632,C,T
| Carboxypeptidase A3 (mast cell) | Novel | 0.074% | R178*
| −5.47 | 0.94 |
TMCO3 - 13,114188422,-,G
| Transmembrane and coiled-coil domains 3 | 0.0326% | 0.742% | A469fs | −1.93 | 0.93 |
SERPINF2 - 17,1649022,CCTG,-
| Serpin peptidase inhibitor, clade F | Novel | 0.080% | A62fs | −1.74 | 0.84 |
PYGL - 14,51383751,G,A
| Phosphorylase, glycogen, liver | 0.0037% | 0.149% | R276C | −0.08 | 0.71 |
FNIP2 - 4,159790466,C,A
| Folliculin interacting protein 2 | 0.0016% | 0.101% | S893*
| −0.86 | 0.58 |
CPPED1 - 16,12758817,G,A
| Calcineurin-like phosphoesterase domain containing 1 | Novel | 0.074% | R149*
| −0.14 | 0.44 |
OR52B4 - 11,4388943,G,A
| Olfactory receptor, family 52, subfamily B, member 4 (gene/pseudogene) | 0.0018% | 0.076% | R195*
| 4.81 | 0.09 |
SCN10A - 3,38755496,G,A
| Sodium channel, voltage gated, type X alpha subunit | 0.0037% | 0.074% | R1155C | 1.62 | 0.08 |
ZNF683 - 1,26694960,G,A
| Zinc finger protein 683 | Novel | 0.089% | R35* | 1.18 | 0.03 |